An update on the contribution of the MHC to as susceptibility

Clinical Rheumatology

Volumn 33, Issue 6, 2014, Pages 749-757

  Reveille, John D ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

Ankylosing spondylitis; Genetics; HLA genes; HLA B27; Major histocompatibility complex; MIC A; Spondylitis; Spondyloarthritis

Indexed keywords

HLA ANTIGEN; HLA ANTIGEN CLASS 1; HLA ANTIGEN CLASS 2; HLA B14 ANTIGEN; HLA B27 ANTIGEN; HLA B40 ANTIGEN; HLA B60 ANTIGEN; HLA DPA1 ANTIGEN; HLA DPB1 ANTIGEN; HLA DQA1 ANTIGEN; HLA DRB1 ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; T LYMPHOCYTE RECEPTOR; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG;

ALLELE; ANKYLOSING SPONDYLITIS; ARTICLE; DISEASE PREDISPOSITION; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENOTYPE; HOMOZYGOSITY; HUMAN; MAJOR HISTOCOMPATIBILITY COMPLEX; MAJOR HISTOCOMPATIBILITY COMPLEX CLASS I CHAIN RELATED GENE A; PRIORITY JOURNAL; T LYMPHOCYTE; ADULT; AGED; FEMALE; GENETIC PREDISPOSITION; GENETICS; GEOGRAPHY; IMMUNOLOGY; MALE; MIDDLE AGED; SPONDYLARTHRITIS; UNITED STATES; YOUNG ADULT;

ADULT; AGED; ALLELES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; GEOGRAPHY; HLA-B27 ANTIGEN; HUMANS; MAJOR HISTOCOMPATIBILITY COMPLEX; MALE; MIDDLE AGED; SPONDYLARTHRITIS; SPONDYLITIS, ANKYLOSING; UNITED STATES; YOUNG ADULT;

EID: 84903816854     PISSN: 07703198     EISSN: 14349949     Source Type: Journal    
DOI: 10.1007/s10067-014-2662-7     Document Type: Article

References (50)

1. Schlosstein L, Terasaki PI, Bluestone R, Pearson CM (1973) High association of an HL-A antigen, W27, with ankylosing spondylitis. N Engl J Med 288:704-706
2. Brewerton DA, Hart FD, Nicholls A et al (1973) Ankylosing spondylitis and HL-A 27. Lancet 301(7809):904-907
3. Cortes A, Hadler J, Pointon JP et al (2013) Multiple novel loci harbouring common and rare variants implicated in ankylosing spondylitis. International Genetics of Ankylosing Spondylitis Consortium (IGAS). Nat Genet 45:730-738
4. Brown MA, Kennedy LG, MacGregor AJ et al (1997) Susceptibility to ankylosing spondylitis in twins: the role of genes, HLA, and the environment. Arthritis Rheum 40:1823-1828 (Pubitemid 27452533)
5. Zhang G, Luo J, Bruckel J et al (2004) Genetic studies in familial ankylosing spondylitis susceptibility. Arthritis Rheum 50:2246-2254 (Pubitemid 38924403)
6. Joshi R, Reveille JD, BrownMA et al (2012) Is there a higher genetic load of susceptibility loci in familial ankylosing spondylitis? Arthritis Care Res (Hoboken) 64:780-784
7. Australo-Anglo-American Spondyloarthritis Consortium (TASC) and the Wellcome Trust Case Control Consortium 2 (WTCCC2) (2011) Genome-wide association study in ankylosing spondylitis identifies further non-MHC associations, and demonstrates that the ERAP1 association is restricted to HLA-B27 positive cases implicating peptide presentation as the likely mechanism underlying the association of HLA-B27 with the disease. Nat Genet 43:761-767
8. WTCCC, TASC (2007) Association scan of 14,500 nsSNPs in four common diseases identifies variants involved in autoimmunity. Nat Genet 39:1329-1337
9. Tam LS, Gu J, Yu D (2010) Pathogenesis of ankylosing spondylitis. Nat Rev Rheumatol 6:399-405
10. Layh-Schmitt G, Colbert RA (2008) The interleukin-23/interleukin-17 axis in spondyloarthritis. Curr Opin Rheum 20:392-397
11. Hannu H, Inman RD, Granfors K, Leirisalo-RepoM(2006) Reactive arthritis or postinfectious arthritis. Best Pract Res Clin Rheum 20:419-433
12. Rosenbaum JT, DaveyMP (2011) Time for a gut check: evidence for the hypothesis that HLA-B27 predisposes to ankylosing spondylitis by altering the microbiome. Arthritis Rheum 63:3195-3198
13. Reveille JD, Maganti RM(2009) Subtypes of HLA-B27: history and implications in the pathogenesis of ankylosing spondylitis. Adv Exp Med Biol 649:159-176
14. Hendel H, Caillat-Zucman S, Lebuanec H et al (1999) New class I and II HLA alleles strongly associated with opposite patterns of progression to AIDS. J Immunol 162:6942-6946 (Pubitemid 29309424)
15. Dorak MT, Tang J, Tang S et al (2003) Influence of human leukocyte antigen-B22 alleles on the course of human immunodeficiency virus type 1 infection in 3 cohorts of white men. J Infect Dis 188:856-863 (Pubitemid 37176032)
16. Roger M (1998) Influence of host genes on HIV-1 disease progression. FASEB J 12:625-632
17. Goulder PJ, Phillips RE, Colbert RA et al (1997) Late escape froman immunodominant cytotoxic T-lymphocyte response associated with progression to AIDS. Nat Med 3:212-217 (Pubitemid 27064707)
18. Streeck H, Lichterfeld M, Alter G et al (2007) Recognition of a defined region within p24 gag by CD8+ T cells during primary human immunodeficiency virus type 1 infection in individuals expressing protective HLA class I alleles. J Virol 81:7725-7731 (Pubitemid 47047858)
19. Martin MP, Gao X, Lee JH et al (2002) Epistatic interaction between KIR3DS1 and HLA-B delays the progression to AIDS. NatGenet 31:429-434 (Pubitemid 35154456)
20. Neumann-Haefelin C (2013) HLA-B27-mediated protection in HIV and hepatitis C virus infection and pathogenesis in spondyloarthritis: two sides of the same coin? Curr Opin Rheumatol 25:426-433
21. Neumann-Haefelin C, Oniangue-Ndza C, Kuntzen T et al (2011) Human leukocyte antigen B27 selects for rare escape mutations that significantly impair hepatitis C virus replication and require compensatory mutations. Hepatology 54:1157-1166
22. Nitschke K, Barriga A, Schmidt J et al (2014) HLA-B*27 sub-type specificity determines targeting and viral evolution of a hepatitis C virus-specific CD8+ T cell epitope. J Hepatol 60:22-29
23. Mathieu A, Paladini F, Vacca A et al (2009) The interplay between the geographic distribution of HLA-B27 alleles and their role in infectious and autoimmune diseases: a unifying hypothesis. Autoimmun Rev 8(5):420-425
24. Reveille JD, Hirsch R, Dillon CF, Carroll MD, Weisman MH (2012) The Prevalence of HLA-B27 in the United States: Data from the U.S. National Health and Nutrition Examination Survey, 2009. Arthritis Rheum 64:1407-1411
25. Breban M (1998) Genetic studies of spondylarthropathies. French Spondylarthropathy Genetic Study Group. Ann Med Interne (Paris) 149:142-144
26. Kawaguchi G, Kato N, Kashiwase K et al (1993) Structural analysis of HLA-B40 epitopes. Hum Immunol 36:193-198 (Pubitemid 23143454)
27. Robinson WP, van der Linden SM, Khan MA et al (1989) HLA-Bw60 increases susceptibility to ankylosing spondylitis in HLA-B27+ patients. Arthritis Rheum 32:1135-1141 (Pubitemid 19237868)
28. Brown MA, Pile KD, Kennedy LG et al (1996) HLA class I associations of ankylosing spondylitis in the white population in the United Kingdom. Ann Rheum Dis 55:268-270 (Pubitemid 26120706)
29. van Gaalen FA, Verduijn W, Roelen DL et al (2013) Epistasis between two HLA antigens defines a subset of individuals at a very high risk for ankylosing spondylitis. Ann Rheum Dis 72:974-978
30. Wei JC, Tsai WC, Lin HS, Tsai CY, Chou CT (2004) HLA-B60 and B61 are strongly associated with ankylosing spondylitis in HLA-B27-negative Taiwan Chinese patients. Rheumatology (Oxford) 43:839-842 (Pubitemid 38996956)
31. López-Larrea C, Mijiyawa M, González S et al (2002) Association of ankylosing spondylitis with HLA-B*1403 in a West African population. Arthritis Rheum 46:2968-2971 (Pubitemid 35315890)
32. Díaz-Peña R, Blanco-Gelaz MA, Njobvu P et al (2008) Influence of HLA-B*5703 and HLA-B*1403 on susceptibi lity to spondyloarthropathies in the Zambian population. J Rheumatol 35:2236-2240
33. Merino Galocha B, Vázquez MN, López de Castro JA (2008) Disparate folding and stability of the ankylosing spondylitis-associated HLA-B*1403 and B*2705 proteins. Arthritis Rheum 58:3693-3704
34. Vargas-Alarcón G, Hernández-Pacheco G, Pacheco-Tena C et al (2002) Effect of HLA-B and HLA-DR genes on susceptibility to and severity of spondyloarthropathies in Mexican patients. Ann Rheum Dis 61:714-717 (Pubitemid 34787709)
35. Mielants, Veys EM, Joos R, Noens L, Cuvelier C, De Vos M (1987) HLA antigens in seronegative spondyloarthropathies. Reactive arthritis and arthritis in ankylosing spondylitis. Relation to gut Inflammation. J Rheumatol. 14:466-471
36. Mielants, Veys EM, De vosM, Cuvelier C et al (1995) The evolution of spondyloarthropathies in relation to gut histology. I. Clinical aspects. J Rheumatol 22:2266-2272.
37. Siala M, Mahfoudh N, Fourati H et al (2009) MHC class I and class II genes in Tunisian patients with reactive and undifferentiated arthritis. Clin Exp Rheumatol 27:208-213
38. Said-Nahal R, Miceli-Richard C, Gautreau C et al (2002) The role of HLA genes in familial spondyloarthropathy: a comprehensive study of 70 multiplex families. Ann Rheum Dis 61:201-206 (Pubitemid 34177748)
39. Wang J, Yang Y, Guo S et al (2013) Association between copy number variations of HLA-DQA1 and ankylosing spondylitis in the Chinese Han population. Genes Immun 14:500-503
40. Ploski R, Flato B, Vinje O et al (1995) Association to HLA-DRB1*08, HLA-DPB1*0301 and homozygosity for an HLA-linked proteasome gene in juvenile ankylosing spondylitis. Hum Immunol 44:88-96
41. Díaz-Peña R, Aransay AM, Bruges-Armas J et al (2011) Fine mapping of a major histocompatibility complex in ankylosing spondylitis: association of the HLA-DPA1 and HLA-DPB1 regions. Arthritis Rheum 63:3305-3312
42. Groh V, Steinle A, Bauer S, Spies T (1998) Recognition of stress-induced MHC molecules by intestinal epithelial gamma-delta Tcells. Science 279:1737-1740 (Pubitemid 28164472)
43. Goto K, Ota M, Ohno S et al (1997) MICA gene and anky losing spondylitis: linkage analysis via a transmembrane-encoded triplet repeat polymorphism. Tissue Antigens 49:503-507 (Pubitemid 27207757)
44. Yabuki K, Ota M, Goto K et al (1999) Triplet repeat polymorphism in the MICA gene in HLA-B27 positive and negative Caucasian patients with ankylosing spondylitis. Hum Immunol 60:83-86 (Pubitemid 29057860)
45. Ricci-Vitiani L, Vacca A, Potolicchio I et al (2000) MICA gene triplet repeat polymorphism in patients with HLA-B27 positive and negative ankylosing spondylitis from Sardinia. J Rheumatol 27:2193-2197
46. Zhou X, Wang J, Zou H, et al. (2013) MICA, a gene contributing strong susceptibility to ankylosing spondylitis.Ann Rheum Dis. Jun 1. [Epub ahead of print]
47. Hohler T, Schaper T, Schneider PM et al (1998) Association of different tumor necrosis factor alpha promoter allele frequencies with ankylosing spondylitis in HLA-B27 positive individuals. Arthritis Rheum 41:1489-1492 (Pubitemid 28373130)
48. Fraile A, Collado MD, Mataran L et al (2000) TAP1 and TAP2 polymorphism in Spanish patients with ankylosing spondylitis. Exp Clin Immunogenet 17:199-204
49. Barron KS, Reveille JD, Carrington M, Mann DL, Robinson MA (1995) Susceptibility to Reiter's syndrome is associated with alleles of TAP genes. Arthritis Rheum 38:684-689
50. Maksymowych WP, Wessler A, Schmitt-Egenolf M et al (1997) Polymorphism in an HLA linked proteasome gene influences phenotypic expression of disease in HLA-B27 positive individuals. J Rheumatol 21:665-669 (Pubitemid 24126762)